Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Childhood Vaccines Market by Type (Recombinant Vaccines, Viral Vaccines, Polysaccharide Vaccines, Others, ), By Application (Hospital, Clinic, ) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Childhood Vaccines Market by Type (Recombinant Vaccines, Viral Vaccines, Polysaccharide Vaccines, Others, ), By Application (Hospital, Clinic, ) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 170808 3300 Pharma & Healthcare 377 234 Pages 4.7 (45)
                                          

Market Overview:


The global childhood vaccines market is expected to grow at a CAGR of 10.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to factors such as rising incidence of infectious diseases, increasing demand for pediatric vaccines, and technological advancements in the vaccine industry. The global childhood vaccines market is segmented on the basis of type into recombinant vaccines, viral vaccines, polysaccharide vaccines, and others. Recombinant vaccine dominates the global childhood vaccine market with a share of more than 50%. This can be attributed to their high efficacy and safety profile. Viral vaccine is expected to grow at a highest CAGR during the forecast period owing to increasing demand for these types of vaccines across emerging economies such as China and India. Polysaccharide vaccine held second largest share in 2017 due its high immunogenicity against encapsulated bacteria pathogens such as Streptococcus pneumoniae (pneumococcus) and Haemophilus influenzae type b (Hib). On the basis of application, hospital segment dominated the global childhood vaccination market with more than 60% share in 2017 followed by clinic segment. Rising number of hospitals coupled with growing awareness about benefits associated with vaccination are key factors driving growth of this segment across globe . Asia Pacific region is anticipated witness highest CAGR over next decade owing rapid economic development which has resulted increased spending on healthcare sector by both public & private players .


Global Childhood Vaccines Industry Outlook


Product Definition:


A Childhood Vaccine is a vaccine administered to children and adolescents. The purpose of childhood vaccines is to protect the recipients from diseases that are potentially fatal or disabling.


Recombinant Vaccines:


Recombinant vaccines are made from the DNA of an animal or human, instead of using the whole virus. Recombinant vaccine works by stimulating the body's immune system to produce antibodies against diseases and not harmful bacteria. The first recombinant vaccine was developed in 1982 for Rheumatoid Arthritis (RA).


Viral Vaccines:


Viral vaccines are made from viruses. These are used to stimulate the immune system to fight against diseases, such as measles, chickenpox, German Measles (rubella), and hepatitis A & B. Viral vaccines can also prevent diseases if given early enough.


The most common viral infections that can be treated using vaccines include: polio (infantile paralysis), rotavirus infection (viral diarrhea), smallpox vaccination, and Hepatitis B infection.


Application Insights:


The hospital application segment accounted for the largest revenue share in 2017. This is due to increasing demand for vaccines in hospitals and other healthcare facilities. Furthermore, rising investments by governments to improve healthcare infrastructure and increase access to quality care will boost industry growth over the forecast period.


Clinic applications are expected to witness significant growth over the forecast period owing to increasing awareness about immunization among pediatricians and family physicians as well as growing emphasis on maintaining community immunity levels. Growing demand for vaccines with less number of injections per child will also propel market growth during this period.


Increasing investments by governments in improving public health infrastructure, along with rising awareness regarding immunization among parents, will drive clinic application segment during the forecast years 2018-2030  to 2030  in North America region especially U.S.


Regional Analysis:


North America dominated the global market in 2017. This can be attributed to high awareness levels regarding vaccination programs, presence of developed healthcare infrastructure, and increasing focus on disease prevention & control strategies by government and non-government organizations. For instance, according to the World Health Organization (WHO), as of 2016 more than 95% population aged 1 year was covered by immunization programs in the U.S., which is a major factor for this region’s dominance in this field.


Asia Pacific is expected to witness lucrative growth over the forecast period owing to rising target population base along with increasing per capita income and improving healthcare infrastructure due to increased foreign investments coupled with favorable regulatory policies implemented by various governments for promoting new vaccine technologies at domestic level will drive regional growth over next eight years till 2030  time frame). Furthermore, growing awareness about vaccines among people especially children is anticipated boost regional demand during forecast period from 2018 till 2030  time frame).


Growth Factors:


  • Increasing incidence of infectious diseases in children
  • Government initiatives and programs for childhood vaccination
  • Growing awareness about the benefits of vaccination among parents
  • Technological advancements in vaccine development and production processes
  • Rising demand for preventive healthcare services

Scope Of The Report

Report Attributes

Report Details

Report Title

Childhood Vaccines Market Research Report

By Type

Recombinant Vaccines, Viral Vaccines, Polysaccharide Vaccines, Others,

By Application

Hospital, Clinic,

By Companies

GSK, Sanofi, Merck, Pfizer, Jintan, CSL, MedImmune LLC, J&J(Crucell), China National Biotec, Tiantan, Hualan, Kangtai, Hissen

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

234

Number of Tables & Figures

164

Customization Available

Yes, the report can be customized as per your need.


Global Childhood Vaccines Market Report Segments:

The global Childhood Vaccines market is segmented on the basis of:

Types

Recombinant Vaccines, Viral Vaccines, Polysaccharide Vaccines, Others,

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Hospital, Clinic,

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. GSK
  2. Sanofi
  3. Merck
  4. Pfizer
  5. Jintan
  6. CSL
  7. MedImmune LLC
  8. J&J(Crucell)
  9. China National Biotec
  10. Tiantan
  11. Hualan
  12. Kangtai
  13. Hissen

Global Childhood Vaccines Market Overview


Highlights of The Childhood Vaccines Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of Alpha Hydroxy Acid for Cosmetic Market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Recombinant Vaccines
    2. Viral Vaccines
    3. Polysaccharide Vaccines
    4. Others
  1. By Application:

    1. Hospital
    2. Clinic
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Childhood Vaccines Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Childhood Vaccines Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available
                                            
1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. Childhood Vaccines Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. Childhood Vaccines Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. Childhood Vaccines Market - Supply Chain
   4.5. Global Childhood Vaccines Market Forecast
      4.5.1. Childhood Vaccines Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. Childhood Vaccines Market Size (000’ Units) and Y-o-Y Growth
      4.5.3. Childhood Vaccines Market Absolute $ Opportunity

5. Global Childhood Vaccines Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. Childhood Vaccines Market Size and Volume Forecast by Type
      5.3.1. Recombinant Vaccines
      5.3.2. Viral Vaccines
      5.3.3. Polysaccharide Vaccines
      5.3.4. Others
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global Childhood Vaccines Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. Childhood Vaccines Market Size and Volume Forecast by Application
      6.3.1. Hospital
      6.3.2. Clinic
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global Childhood Vaccines Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. Childhood Vaccines Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global Childhood Vaccines Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. Childhood Vaccines Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global Childhood Vaccines Demand Share Forecast, 2019-2026

9. North America Childhood Vaccines Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America Childhood Vaccines Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America Childhood Vaccines Market Size and Volume Forecast by Application
      9.4.1. Hospital
      9.4.2. Clinic
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America Childhood Vaccines Market Size and Volume Forecast by Type
      9.7.1. Recombinant Vaccines
      9.7.2. Viral Vaccines
      9.7.3. Polysaccharide Vaccines
      9.7.4. Others
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America Childhood Vaccines Demand Share Forecast, 2019-2026

10. Latin America Childhood Vaccines Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America Childhood Vaccines Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America Childhood Vaccines Market Size and Volume Forecast by Application
      10.4.1. Hospital
      10.4.2. Clinic
    10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America Childhood Vaccines Market Size and Volume Forecast by Type
      10.7.1. Recombinant Vaccines
      10.7.2. Viral Vaccines
      10.7.3. Polysaccharide Vaccines
      10.7.4. Others
    10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America Childhood Vaccines Demand Share Forecast, 2019-2026

11. Europe Childhood Vaccines Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe Childhood Vaccines Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe Childhood Vaccines Market Size and Volume Forecast by Application
      11.4.1. Hospital
      11.4.2. Clinic
    11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projections by Application
   11.7. Europe Childhood Vaccines Market Size and Volume Forecast by Type
      11.7.1. Recombinant Vaccines
      11.7.2. Viral Vaccines
      11.7.3. Polysaccharide Vaccines
      11.7.4. Others
    11.8. Basis Point Share (BPS) Analysis by Type
   11.9. Y-o-Y Gowth Projections by Type
   11.10. Market Attractiveness/Growth Potential Analysis
      11.10.1. By Country
      11.10.2. By Product Type
      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe Childhood Vaccines Demand Share, 2019-2026

12. Asia Pacific Childhood Vaccines Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific Childhood Vaccines Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific Childhood Vaccines Market Size and Volume Forecast by Application
      12.4.1. Hospital
      12.4.2. Clinic
    12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific Childhood Vaccines Market Size and Volume Forecast by Type
      12.7.1. Recombinant Vaccines
      12.7.2. Viral Vaccines
      12.7.3. Polysaccharide Vaccines
      12.7.4. Others
    12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific Childhood Vaccines Demand Share, 2019-2026

13. Middle East & Africa Childhood Vaccines Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa Childhood Vaccines Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa Childhood Vaccines Market Size and Volume Forecast by Application
      13.4.1. Hospital
      13.4.2. Clinic
    13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa Childhood Vaccines Market Size and Volume Forecast by Type
      13.7.1. Recombinant Vaccines
      13.7.2. Viral Vaccines
      13.7.3. Polysaccharide Vaccines
      13.7.4. Others
    13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa Childhood Vaccines Demand Share, 2019-2026

14. Competition Landscape
   14.1. Global Childhood Vaccines Market: Market Share Analysis
   14.2. Childhood Vaccines Distributors and Customers
   14.3. Childhood Vaccines Market: Competitive Dashboard
   14.4. Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.4.1. GSK
         14.4.1.1. Overview
         14.4.1.2. Financials
         14.4.1.3. Developments
         14.4.1.4. Strategic Outlook
      14.4.2. Sanofi
         14.4.2.1. Overview
         14.4.2.2. Financials
         14.4.2.3. Developments
         14.4.2.4. Strategic Outlook
      14.4.3. Merck
         14.4.3.1. Overview
         14.4.3.2. Financials
         14.4.3.3. Developments
         14.4.3.4. Strategic Outlook
      14.4.4. Pfizer
         14.4.4.1. Overview
         14.4.4.2. Financials
         14.4.4.3. Developments
         14.4.4.4. Strategic Outlook
      14.4.5. Jintan
         14.4.5.1. Overview
         14.4.5.2. Financials
         14.4.5.3. Developments
         14.4.5.4. Strategic Outlook
      14.4.6. CSL
         14.4.6.1. Overview
         14.4.6.2. Financials
         14.4.6.3. Developments
         14.4.6.4. Strategic Outlook
      14.4.7. MedImmune LLC
         14.4.7.1. Overview
         14.4.7.2. Financials
         14.4.7.3. Developments
         14.4.7.4. Strategic Outlook
      14.4.8. J&J(Crucell)
         14.4.8.1. Overview
         14.4.8.2. Financials
         14.4.8.3. Developments
         14.4.8.4. Strategic Outlook
      14.4.9. China National Biotec
         14.4.9.1. Overview
         14.4.9.2. Financials
         14.4.9.3. Developments
         14.4.9.4. Strategic Outlook
      14.4.10. Tiantan
         14.4.10.1. Overview
         14.4.10.2. Financials
         14.4.10.3. Developments
         14.4.10.4. Strategic Outlook
      14.4.11. Hualan
         14.4.11.1. Overview
         14.4.11.2. Financials
         14.4.11.3. Developments
         14.4.11.4. Strategic Outlook
      14.4.12. Kangtai
         14.4.12.1. Overview
         14.4.12.2. Financials
         14.4.12.3. Developments
         14.4.12.4. Strategic Outlook
      14.4.13. Hissen
         14.4.13.1. Overview
         14.4.13.2. Financials
         14.4.13.3. Developments
         14.4.13.4. Strategic Outlook
      14.4.14. COMPANY 14
         14.4.14.1. Overview
         14.4.14.2. Financials
         14.4.14.3. Developments
         14.4.14.4. Strategic Outlook
      14.4.15. COMPANY 15
         14.4.15.1. Overview
         14.4.15.2. Financials
         14.4.15.3. Developments
         14.4.15.4. Strategic Outlook
      14.4.16. COMPANY 16
         14.4.16.1. Overview
         14.4.16.2. Financials
         14.4.16.3. Developments
         14.4.16.4. Strategic Outlook
      14.4.17. COMPANY 17
         14.4.17.1. Overview
         14.4.17.2. Financials
         14.4.17.3. Developments
         14.4.17.4. Strategic Outlook
      14.4.18. COMPANY 18
         14.4.18.1. Overview
         14.4.18.2. Financials
         14.4.18.3. Developments
         14.4.18.4. Strategic Outlook
      14.4.19. COMPANY 19
         14.4.19.1. Overview
         14.4.19.2. Financials
         14.4.19.3. Developments
         14.4.19.4. Strategic Outlook
      14.4.20. COMPANY 20
         14.4.20.1. Overview
         14.4.20.2. Financials
         14.4.20.3. Developments
         14.4.20.4. Strategic Outlook

Our Trusted Clients

Contact Us